145 related articles for article (PubMed ID: 16299404)
1. Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: an immunohistochemical study.
Wang SL; Chen WT; Wu MT; Chan HM; Yang SF; Chai CY
Endocr Pathol; 2005; 16(3):211-8. PubMed ID: 16299404
[TBL] [Abstract][Full Text] [Related]
2. Expression of human telomerase reverse transcriptase (hTERT) in thyroid neoplasms.
Sayiner A; Suren D
J BUON; 2018; 23(1):229-233. PubMed ID: 29552789
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M
Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Anticancer Res; 2005; 25(1B):509-14. PubMed ID: 15816620
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.
Asaad NY; Abd El-Wahed MM; Mohammed AG
J Egypt Natl Canc Inst; 2006 Mar; 18(1):8-16. PubMed ID: 17237847
[TBL] [Abstract][Full Text] [Related]
8. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
[TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
12. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
[TBL] [Abstract][Full Text] [Related]
13. The potential diagnostic value of Rac1 immunohistochemistry in follicular thyroid carcinoma.
Agustina H; Ahyati R; Suryanti S; Hernowo BS
Malays J Pathol; 2022 Aug; 44(2):225-233. PubMed ID: 36043585
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of cyclooxygenase 2 in follicular carcinomas of the thyroid.
Haynik DM; Prayson RA
Arch Pathol Lab Med; 2005 Jun; 129(6):736-41. PubMed ID: 15913419
[TBL] [Abstract][Full Text] [Related]
16. Metalloproteinase-9 immunoexpression and angiogenesis in thyroid follicular neoplasms: relation to clinical and histopathologic features.
FrigugliettI CU; Mello ES; Castro IV; Filho GB; Alves VA
Head Neck; 2000 Jul; 22(4):373-9. PubMed ID: 10862021
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
Barresi V; Leni A; Tuccari G; Barresi G
Histol Histopathol; 2012 Mar; 27(3):329-36. PubMed ID: 22237710
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in benign and malignant human thyroid tissues.
Cheng AJ; Lin JD; Chang T; Wang TC
Br J Cancer; 1998 Jun; 77(12):2177-80. PubMed ID: 9649130
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]